Co-regulated expression of TGF-β variants and miR-21 in bladder cancer

Urology Journal

Volumn 10, Issue 3, 2013, Pages 981-987

  Monfared, Hamideh ^a   Ziaee, Seyed Amir Mohsen ^b   Hashemitabar, Mahmoud ^c   Khayatzadeh, Hamid ^a   Kheyrollahi, Vahid ^a,d   Tavallaei, Mahmood ^e   Mowla, Seyed Javad ^a  

^a TARBIAT MODARES UNIVERSITY   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c AHVAZ JUNDISHAPUR UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d Pars Oil Company Research and Development Dept   (Iran)

^e BAQIYATALLAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Analysis; Biological markers; Gene expression profiling; miR 21; TGF ; Urinary bladder neoplasms

Indexed keywords

MICRORNA; MIRN21 MICRORNA, HUMAN; TRANSFORMING GROWTH FACTOR BETA;

ADULT; AGED; ARTICLE; BIOSYNTHESIS; BLADDER TUMOR; CELL CULTURE; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; MALE; METABOLISM; MIDDLE AGED; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CELLS, CULTURED; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MICRORNAS; MIDDLE AGED; TRANSFORMING GROWTH FACTOR BETA; URINARY BLADDER NEOPLASMS;

EID: 84889632837     PISSN: 17351308     EISSN: 1735546X     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Dyrskjot L, Zieger K, Orntoft TF. Recent advances in high-throughput molecular marker identification for superficial and invasive bladder cancers. Front Biosci. 2007;12:2063-73.
2. Croce CM, Calin GA. MiRNAs, cancer, and stem cell division. Cell. 2005;122:6-7.
3. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116:281-297.
4. Calin GA, Sevignani C, Dumitru CD et al. Human microRNA genes are frequently located at fragile sites and genomic region sinvolved in cancers. Proc Natl Acad Sci USA. 2004;101:2999-3004.
5. Esquela-Kerscher A, Slack FJ. Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer. 2006;6:259-69.
6. Baffa R, Fassan M, Volinia S et al. MicroRNA expression profiling of human metastatic cancers identifies cancer gene targets. J Patholo. 2009;219:214-221.
7. Zhu S, Wu H, Wu Fet al. MicroRNA-21 targets tumor suppressor genes in invasion and metastasis. Cell Res. 2008;18:350-359.
8. Asangani IA, Rasheed SAK, Nikolova DA,et al. MicroRNA-21 (miR- 21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasion and metastasis in colorectal cancer. Oncogene. 2008;27:2128-2136.
9. Yan LX, Huang XF, Shao Q, et al. MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis. RNA. 2008;14:2348-2360.
10. Davis BN, Hilyard AC, Lagna G, Hata A. SMAD proteins control DROSHA- mediated microRNA maturation. Nature. 2008;454:56-61.
11. Massague J. TGF-β in Cancer. J Cell. 2008;134:215-230.
12. Keski-Oja1 J, Koli K, von Melchner H. TGF-β activation by traction? J Cell Biology. 2004;14:657-659.
13. Gorsch SM, Memoli VA, Stukel TA, et al. Immunohistochemical staining for TGF-β1 associates with disease progression in human breast cancer. Cancer Res. 1992;52:6949-6952.
14. Thompson TC, Truong LD, Timme TL, et al. Transforming growth factor β1as a biomarker for prostate cancer. J Cell Biochem. 1992; 16H:54-61 15. Weidner N, Semple JP, Welch WR, Folkman J. Tumor angiogenesis and metastasis - correlation in invasive breast carcinoma. N Engl J Med. 1991;324:1-8.
15. Eder IE, Stenzl A, Hobisch A, et al. Transforming growth factors-beta 1 and beta 2 in serum and urine from patients with bladder carcinoma. J Urol. 1996;156:953-7.
16. Huang SS, Huang JS. TGF-beta control of cell proliferation. J Cell Biochem. 2005; 96(3):447-62.
17. Coombes RC, Barrett-Lee P, Luqmani Y. Growth factor expression in breast tissue. J Steroid Biochem Mol Biol. 1990;37:833-6.
18. Jonson T, Albrechtsson E, Axelson J, et al. Altered expression of TGFB receptors and mitogenic effects of TGFB in pancreatic carcinomas. Int J Oncol. 2001;19:71-81.
19. Ryu B, Kern SE. The essential similarity of TGF beta and activin receptor transcriptional responses in cancer cells. Cancer Biol Ther. 2003;2:164-70.
20. Johnson MD, Shaw AK, O'Connell MJ et al. Analysis of transforming growth factor β receptor expression and signaling in higher grade meningiomas. J Neurooncol. 2011;103:277-85.
21. Kim SH, Lee SH, Choi YL et al. Extensive alteration in the expression profiles of TGFB pathway signaling components and TP53 is observed along the gastric dysplasia-carcinoma sequence. Histol Histopathol. 2008; 23:1439-52.
22. Bertucci F, Finetti P, Cervera N et al. How different are luminal A and basal breast cancers? Int J Cancer. 2009;124:1338-48.
23. Wang JC, Su CC, Xu JB et al. Novel microdeletion in the transforming growth factor beta type II receptor gene is associated with giant and large cell variants of non-small cell lung carcinoma. Genes Chromosomes Cancer. 2007;46:192-201.
24. Guzinska-Ustymowicz K, Kemona A. Transforming growth factor beta can be a parameter of aggressiveness of pT1 colorectal cancer. World J Gastroenterol. 2005;11:1193-5.
25. Barlow J, Yandell D, Weaver D et al. Higher stromal expression of transforming growth factor-beta type II receptors is associated with poorer prognosis breast tumors. Breast Cancer Res Treat. 2003;79:149-59.
26. Eder IE, Stenzl A, Hobisch A et al. Expression of transforming growth factors beta-1, beta 2 and beta 3 in human bladder carcinomas. Br J Cancer. 1997;75:1753-60.
27. Selcuklu SD, Donoghue MT, Spillane C. miR-21 as a key regulator of oncogenic processes. Biochem Soc Trans. 2009;37:918-25.
28. Pan X, Wang ZX, Wang R. MicroRNA-21: a novel therapeutic target in human cancer. Cancer Biol Ther. 2011;10:1224-32.